0.9000
0.0000
(0.00%)
At close: January 29 at 3:00:00 PM EST
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Gerhard Lobmaier | Chief Operations Officer | -- | -- | 1969 |
Thomas Schneckenburger C.F.A., Ph.D. | Head of Investor & Corporate Relations | -- | -- | -- |
Philipp Frech | General Counsel & Secretary of the Board | -- | -- | -- |
Ms. Anne De Vos | Head of Sales | -- | -- | 1964 |
Ms. Astrid Schafer | Head of Innovation | -- | -- | 1973 |
Dr. Luc Gruner | Executive Officer | -- | -- | 1952 |
Evolva Holding SA
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Evolva Holding SA is in the process of liquidation of its remaining assets. Previously, the company was engaged in discovery, research, development, and commercialization of nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. The company was incorporated in 2001 and is headquartered in Reinach, Switzerland.
Corporate Governance
Evolva Holding SA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 20, 2025 at 10:59 AM UTC - March 24, 2025 at 12:00 PM UTC
Evolva Holding SA Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
BIXT Bioxytran, Inc.
0.0900
-6.93%
RSPI RespireRx Pharmaceuticals Inc.
0.0024
0.00%
EDSA Edesa Biotech, Inc.
1.8900
+1.07%
DRMA Dermata Therapeutics, Inc.
1.2000
-0.83%
WINT Windtree Therapeutics, Inc.
0.1340
-6.23%
PTN Palatin Technologies, Inc.
0.9000
-0.99%
BMRN BioMarin Pharmaceutical Inc.
63.88
+0.66%
EYEN Eyenovia, Inc.
0.0349
-6.18%
OCEA Ocean Biomedical, Inc.
0.1895
-22.05%
HEPA Hepion Pharmaceuticals, Inc.
0.1866
+5.42%